This section describes the conditions that Washington's health care facilities must notify public health authorities of on a statewide basis. The board finds that the conditions in Table HF-1 of this section are notifiable for the prevention and control of communicable and noninfectious diseases and conditions.
(1) Health care facilities shall notify public health authorities of cases that occur in their facilities of the conditions identified in Table HF-1 of this section following the requirements in WAC
. This is not intended to require health care facilities to confirm the absence of conditions listed in Table HF-1 in facility patients.
(2) Health care facilities may choose to assume the notification for their health care providers for conditions designated in Table HF-1 of this section.
(3) Health care facilities may not assume the reporting requirements of laboratories that are components of the health care facility.
(4) Local health officers may require additional conditions to be notifiable within the local health officer's jurisdiction.
| Notifiable Condition | Time Frame for Notification | Notifiable to Local Health Department | Notifiable to State Department of Health |
| Acquired Immunodeficiency Syndrome (AIDS) | Within 3 business days | | √ |
| Animal Bites (when human exposure to rabies is suspected) | Immediately | √ | |
| Anthrax | Immediately | √ | |
| Arboviral Disease (acute disease only including, but not limited to, West Nile virus, eastern and western equine encephalitis, dengue, St. Louis encephalitis, La Crosse encephalitis, Japanese encephalitis, and Powassan) | Within 3 business days | √ | |
| Asthma, occupational | Monthly | | √ |
| Birth Defects Abdominal Wall Defects (inclusive of gastroschisis and omphalocele) | Monthly | | √ |
| Birth Defects Autism Spectrum Disorders | Monthly | | √ |
| Birth Defects Cerebral Palsy | Monthly | | √ |
| Birth Defects Down Syndrome | Monthly | | √ |
| Birth Defects Alcohol Related Birth Defects | Monthly | | √ |
| Birth Defects Hypospadias | Monthly | | √ |
| Birth Defects Limb reductions | Monthly | | √ |
| Birth Defects Neural Tube Defects (inclusive of anencephaly and spina bifida) | Monthly | | √ |
| Birth Defects Oral Clefts (inclusive of cleft lip with/without cleft palate) | Monthly | | √ |
| Botulism (foodborne, infant, and wound) | Immediately | √ | |
| Brucellosis (Brucella species) | Within 24 hours | √ | |
| Burkholderia mallei (Glanders) and pseudomallei (Melioidosis) | Immediately | √ | |
| Cancer (See chapter 246-430 WAC) | Monthly | | √ |
| Chancroid | Within 3 business days | √ | |
| Chlamydia trachomatis infection | Within 3 business days | √ | |
| Cholera | Immediately | √ | |
| Cryptosporidiosis | Within 3 business days | √ | |
| Cyclosporiasis | Within 3 business days | √ | |
| Diphtheria | Immediately | √ | |
| Disease of suspected bioterrorism origin | Immediately | √ | |
| Domoic acid poisoning | Immediately | √ | |
| E. coli Refer to "Shiga toxin-producing E. coli" | Immediately | √ | |
| Emerging condition with outbreak potential | Immediately | √ | |
| Giardiasis | Within 3 business days | √ | |
| Gonorrhea | Within 3 business days | √ | |
| Granuloma inguinale | Within 3 business days | √ | |
| Gunshot wounds (nonfatal) | Monthly | | √ |
| Haemophilus influenzae (invasive disease, children under age 5) | Immediately | √ | |
| Hantavirus pulmonary syndrome | Within 24 hours | √ | |
| Hepatitis A (acute infection) | Within 24 hours | √ | |
| Hepatitis B (acute infection) | Within 24 hours | √ | |
| Hepatitis B surface antigen pregnant women | Within 3 business days | √ | |
| Hepatitis B (chronic infection) Initial diagnosis, and previously unreported prevalent cases | Monthly | √ | |
| Hepatitis C Acute infection | Within 3 business days | √ | |
| Hepatitis C Chronic infection | Monthly | √ | |
| Hepatitis D (acute and chronic infection) | Within 3 business days | √ | |
| Hepatitis E (acute infection) | Within 24 hours | √ | |
| Human immunodeficiency virus (HIV) infection | Within 3 business days | √ | |
| Influenza, novel or unsubtypable strain | Immediately | √ | |
| Influenza-associated death (laboratory confirmed) | Within 3 business days | √ | |
| Legionellosis | Within 24 hours | √ | |
| Leptospirosis | Within 24 hours | √ | |
| Listeriosis | Within 24 hours | √ | |
| Lyme Disease | Within 3 business days | √ | |
| Lymphogranuloma venereum | Within 3 business days | √ | |
| Malaria | Within 3 business days | √ | |
| Measles (rubeola) Acute disease only | Immediately | √ | |
| Meningococcal disease (invasive) | Immediately | √ | |
| Monkeypox | Immediately | √ | |
| Mumps (acute disease only) | Within 24 hours | √ | |
| Outbreak of suspected foodborne origin | Immediately | √ | |
| Outbreak of suspected waterborne origin | Immediately | √ | |
| Paralytic shellfish poisoning | Immediately | √ | |
| Pertussis | Within 24 hours | √ | |
| Pesticide poisoning (hospitalized, fatal, or cluster) | Immediately | | √ |
| Plague | Immediately | √ | |
| Poliomyelitis | Immediately | √ | |
| Prion disease | Within 3 business days | √ | |
| Psittacosis | Within 24 hours | √ | |
| Q Fever | Within 24 hours | √ | |
| Rabies (Confirmed Human or Animal) | Immediately | √ | |
| Rabies, suspected human exposure (suspected human rabies exposures due to a bite from or other exposure to an animal that is suspected of being infected with rabies) | Immediately | √ | |
| Relapsing fever (borreliosis) | Within 24 hours | √ | |
| Rubella, acute disease only (including congenital rubella syndrome) | Immediately | √ | |
| Salmonellosis | Within 24 hours | √ | |
| SARS | Immediately | √ | |
| Serious adverse reactions to immunizations | Within 3 business days | √ | |
| Shiga toxin-producing E. coli infections (enterohemorrhagic E. coli including, but not limited to, E. coli O157:H7) | Immediately | √ | |
| Shigellosis | Within 24 hours | √ | |
| Smallpox | Immediately | √ | |
| Syphilis | Within 3 business days | √ | |
| Tetanus | Within 3 business days | √ | |
| Trichinosis | Within 3 business days | √ | |
| Tuberculosis | Immediately | √ | |
| Tularemia | Immediately | √ | |
| Vaccinia transmission | Immediately | √ | |
| Vancomycin-resistant Staphylococcus aureus (not to include vancomycin-intermediate) | Within 24 hours | √ | |
| Varicella-associated death | Within 3 business days | √ | |
| Vibriosis | Within 24 hours | √ | |
| Viral hemorrhagic fever | Immediately | √ | |
| Yellow fever | Immediately | √ | |
| Yersiniosis | Within 24 hours | √ | |
| Other rare diseases of public health significance | Within 24 hours | √ | |
| Unexplained critical illness or death | Within 24 hours | √ | |